Chengdu, China

Jiangjiang Hu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ampsource Biopharma Shanghai Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiangjiang Hu. Retrieved from https://idiyas.com/inventor/jiangjiang-hu-bleyyezz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Jiangjiang Hu: Innovator in Antibody Research**

Introduction: **Jiangjiang Hu** is a prominent inventor based in **Chengdu, CN**, recognized for his significant contributions to the field of biopharmaceuticals. His innovative approach towards antibody development serves as a vital step in addressing complex medical challenges.

Latest Patents: Jiangjiang Hu's notable patent, titled *Antibody against TIM-3 and application thereof*, encompasses a groundbreaking antibody targeting human TIM-3. This invention also includes a nucleic acid molecule that encodes the antibody, an expression vector for its production, and a host cell for expression. Furthermore, it outlines a pharmaceutical composition containing the antibody or its fragments, along with its application for creating a medicine aimed at preventing and treating various diseases, including tumors, infectious diseases, and autoimmune conditions.

Career Highlights: Jiangjiang Hu is currently affiliated with **Ampsource Biopharma Shanghai Inc.**, where his expertise is pivotal in advancing their scientific endeavors. His work is characterized by a commitment to innovation and improving healthcare outcomes.

Collaborations: His collaborative efforts with esteemed colleagues, including **Qiang Li** and **Tongtong Xue**, have enriched the research environment, fostering a culture of innovation and shared knowledge within the organization.

Conclusion: In summary, Jiangjiang Hu's contributions to antibody research through his patent on TIM-3 demonstrate the potential of innovative solutions in the biopharmaceutical landscape. His work not only advances scientific understanding but also holds promise for significant therapeutic applications in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…